We are live on
!
Find out more
YF
Yu Fan Portfolio holdings
AUM
$97M
1-Year Est. Return
57.2%
This Fund
S&P 500
This Quarter
Est. Return
-23.64%
1 Year Est. Return
+57.2%
3 Year Est. Return
-14.37%
5 Year Est. Return
-61.92%
10 Year Est. Return
–
AUM
$76.5M
AUM Growth
+$3.99M
(+5.5%)
Cap. Flow
+$11.4M
Cap. Flow
% of AUM
14.94%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
4
Increased
–
Reduced
–
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CG Oncology
CGON
|
+$54.7M |
| 2 |
CRGX
CARGO Therapeutics
CRGX
|
+$17.3M |
| 3 |
ALMS
Alumis Inc
ALMS
|
+$10.5M |
| 4 |
Castle Biosciences
CSTL
|
+$819K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prenetics Global
PRE
|
+$55M |
| 2 |
Spyre Therapeutics
SYRE
|
+$16.4M |
| 3 |
SONX
Sonendo, Inc.
SONX
|
+$498K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
CG Oncology
CGON
$6.34B
| $49.8M | 65.11% |
+1,578,344
| New | +$54.7M |
|
|
CRGX
2
DELISTED
CARGO Therapeutics
CRGX
| $15M | 19.57% |
+912,000
| New | +$17.3M |
|
|
ALMS
3
Alumis Inc
ALMS
$3.65B
| $10.5M | 13.72% |
+789,618
| New | +$10.5M |
|
|
4
Castle Biosciences
CSTL
$733M
| $800K | 1.05% |
+36,747
| New | +$819K |
|
5
Pyxis Oncology
PYXS
$150M
| $229K | 0.3% |
69,303
| – | – |
|
6
Sagimet Biosciences
SGMT
$483M
| $196K | 0.26% |
57,190
| – | – |
|
|
7
Prenetics Global
PRE
$311M
| – | – |
-1,252,438
| Closed | -$55M |
|
|
8
Spyre Therapeutics
SYRE
$8.7B
| – | – |
-737,000
| Closed | -$16.4M |
|
|
SONX
9
DELISTED
Sonendo, Inc.
SONX
| – | – |
-22,503
| Closed | -$498K |
|
Similar funds
PWM
ACM
AWP
SFO
CSW
TFS
FA
JKSF
Yu Fan's Q2 2024 Portfolio in Review
As of Q2 2024, Yu Fan held 9 positions worth $76.5M, up 5.5% from $72.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Yu Fan deployed $11.4M of net new capital in Q2 2024, opening 4 new positions. Its largest new stake was CG Oncology: 1,578,344 shares worth $49.8M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 24% a quarter earlier, followed by Consumer Staples.
On the sell side, the most notable exit was Prenetics Global, an estimated $55M sold.
- Yu Fan's largest Q2 2024 buy was CG Oncology: 1,578,344 shares worth $49.8M.
- Yu Fan fully exited Prenetics Global in Q2 2024, selling an estimated $55M.
- Yu Fan's ten largest holdings make up 100% of its $76.5M portfolio in Q2 2024.
- Yu Fan opened 4 new positions and closed 3 in Q2 2024.
- Yu Fan's portfolio value rose 5.5% quarter-over-quarter to $76.5M.
Based on Yu Fan's 13F filing for Q2 2024, filed 14 Aug 2024.